Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Managed Care June 2004	Use of Attention-Deficit Medications Surges 369 Percent in Children Under 5 ADHD medication spending for pediatric patients outpaces antibiotics, allergy, and asthma treatments.
American Family Physician November 1, 2000	When Adults Have ADHD Attention-deficit/hyperactivity disorder is also called ADHD. People with ADHD are hyperactive or distracted most of the time. Even when they try to concentrate, they find it hard to pay attention...
The Motley Fool June 30, 2008 Brian Orelli	Johnson & Johnson Grows Up a Little Its Concerta for attention-deficit disorder is approved for use in adults.
BusinessWeek October 27, 2003 Catherine Arnst	Attention Deficit: Not Just Kid Stuff Drugmakers are starting to target an overlooked group: Adults with ADHD.
Managed Care July 2005	Cost being equal, consumers prefer older drugs Seven out of 10 consumers would prefer a drug that had been on the market for 10 years or more, compared to a newer drug, even if the copayments were equal. This could be a sign that consumers are more inclined to start using generic medications.
Managed Care June 2005	Headlines On Deadline ... Many jobs available to young adults pay little... Prescription medications are getting more difficult to afford...
The Motley Fool February 25, 2010 Brian Orelli	An Untouched Market Waiting to Be Captured Unfilled prescriptions are a potential boon to drug companies.
American Family Physician May 1, 2001	Learning About ADHD in Children ADHD, or attention-deficit/hyperactivity disorder, is a common health problem in children. Children with ADHD are hyperactive--they can't sit still. They are also impulsive and easily distracted. They have trouble coping at school and at home...
Managed Care January 2004	Increasing drug copayments deter compliance Raising copayments in tiered prescription drug plans increases the likelihood that patients will stop taking prescribed medications, according to a recent study published in the New England Journal of Medicine.
BusinessWeek March 27, 2006 Gene G. Marcial	Cortex Draws A Bead On Hyperactivity When Cortex Pharmaceuticals disclosed on Mar. 8 that its lead drug, CX717, showed favorable results in Phase 2 trials for the treatment of adult ADHD, the stock jumped.
American Family Physician November 1, 2000 Searight, Burke & Rottnek	Adult ADHD: Evaluation and Treatment in Family Medicine Attention-deficit/hyperactivity disorder (ADHD) affects 30 to 50 percent of adults who had ADHD in childhood. Accurate diagnosis of ADHD in adults is challenging and requires attention to early development and symptoms of inattention, distractibility, impulsivity and emotional lability...
Managed Care June 2007	Seventy Percent Surge In Diabetes Spending Spending on endocrine and diabetes therapies could surge nearly 70% in the next two years, according to research. Diabetes treatments were the second leading contributor in total dollars to prescription drug spending growth in 2006.
Salon.com May 23, 2002 Lawrence H. Diller	A prescription for disaster The failure to test the effects in children of routinely prescribed drugs has resulted in at least one death. How many kids will die before drug companies take steps to ensure their safety?
Scientific American July 2005 Gunjan Sinha	Training the Brain Cognitive therapy as an alternative to ADHD drugs.
Managed Care September 2004	Cost-Related Underuse of Heart Meds Leads to Cardiac Complications The study is significant because it is the first nationally representative longitudinal study to demonstrate that patients with serious chronic illnesses experience adverse health events when they restrict their use of prescription drugs due to cost.
Managed Care September 2007	Income Said To Influence Use of Generics An observational analysis of pharmacy claims collected from 2001 to 2003 finds that where a person lives and the socioeconomic implications of that location have a lot do with his use of generic drugs.
ifeminists May 24, 2006 Gerald K. McOscar	ADHD Is it child abuse per se for parents to allow doctors to prescribe mind altering drugs with potentially serious or fatal psychiatric side effects to their children, no matter how challenged...or challenging?
Nurse Practitioner April 2009 Tamara Zurakowski	The practicalities and pitfalls of polypharmacy A working knowledge of the pharmacokinetics of aging and basic pharmacodynamics of medications in the older adult is needed to appropriately care for elders.
AskMen.com Dave Golokhov	Mental Health And Women A new report shows that one in four American women use prescription medication to combat mental disorders, and the numbers are on the rise.
Salon.com October 18, 2001 Lawrence H. Diller	An end run to marketing victory Drug makers find ways to circumvent an advertising ban and promote psychiatric drugs for children...
Salon.com October 25, 2000 Cynthia Kuhn & Wilkie Wilson	Cured but worried I've been taking medication for my attention-deficit disorder. The drug really helps, but I'm afraid of its long-term effects...
Salon.com March 9, 2000 Lawrence H. Diller, M.D.	Kids on drugs A behavioral pediatrician questions the wisdom of medicating our children.
Managed Care August 2007	Headlines On Deadline ... A survey finds that many employees struggle with basic health benefit terms... Old matches new when it comes to oral diabetes drugs...
American Family Physician September 1, 2001 William D. Smucker & Marjaneh Hedayat	Evaluation and Treatment of ADHD Symptoms of attention-deficit/hyperactivity disorder (ADHD) are present in as many as 9 percent of school-age children. ADHD-specific questionnaires can help determine whether children meet diagnostic criteria for the disorder...
CFO June 1, 2010 Alix Stuart	"This Is the Era of Smarter Medicine." A prescription-drug provider says it can thrive even as it helps drive down health-care costs. An interview with Richard Rubino, CFO, Medco Health Solutions Inc.
BusinessWeek December 22, 2003 Howard Gleckman	Seniors' Big Drug Problem Misusing medications is a leading cause of death among the elderly.
American Family Physician October 15, 2001 Michael L. Szymanski	Attention-Deficit/Hyperactivity Disorder: Management Attention-deficit/hyperactivity disorder (ADHD) is the most common psychiatric disorder of childhood and often persists into adulthood. With time and interest, the family physician can develop the skills needed to treat this disorder...
BusinessWeek January 21, 2010 John Carey	Making Personalized Medicine Pay Medco and other pharmacy benefit managers say future profits depend on matching drugs to patients based on their genes.
Managed Care November 2003	States exempt psychiatric drugs in some Medicaid programs While states are implementing broad policies to control Medicaid costs, outpatient prescription psychiatric drugs are falling into newly created exemptions, according to a recent survey conducted by the Bazelon Center for Mental Health Law.
The Motley Fool October 30, 2006 Brian Lawler	Building a Future Shire ADHD drugs are big for Shire now, but the long term isn't as clear. Investors, take note.
Managed Care November 2001	Drug Discount Cards May Not Be Full Answer A fair number of consumers have turned to discount prescription cards to help pay for medications but the value of these cards is in doubt...
Searcher June 2012 Stephanie C. Ardito	The Medical Digital: How Safe Are the Prescription Drugs we Take? Monitoring Adverse Events and Recalls For general information about prescription and clinical trial drugs, the following websites have been around for a while and have excellent reputations.
Managed Care March 2001	Does Cost-Sharing For Drugs Lead To Adverse Events? A study in the Journal of the American Medical Association suggests that HMOs' increased use of cost-sharing to soften prescription drug expenses may have actually increase overall medical costs over the long term.
The Motley Fool August 19, 2004 Charly Travers	1 Pill for Sleep, Attention Ailments? Cephalon gets some good news about its drug PROVIGIL.
BusinessWeek April 18, 2005	Making Those Pills Safe For Kids Few medicines get tested on children. Dr. Donald Mattison is pushing to change that.
The Motley Fool May 2, 2007 Mike Havrilla	Consider Cortex New findings may give Cortex's ADHD drug the lift it needs. The news represents an excellent opportunity for speculative biotech investors
ifeminists September 15, 2004 Wendy McElroy	Mandatory Mental Health Screening Threatens Privacy, Parental Rights The screenings may be used to force parents to put their children on psychiatric medication. Some parents who have refused to do so under current policies have been threatened or charged with "child abuse" for no other reason than their refusal.
BusinessWeek August 22, 2005 Gene G. Marcial	New River May Have A "Blockbuster" For ADHD New River Pharmaceuticals has yet to make a dime - but investors love it.
The Motley Fool December 6, 2007 Selena Maranjian	Your Drugs Are in the Mail Order medications online and save. According to a study by the Lewin Group, mail-order pharmacies, such as Medco and Express Scripts, can save you as much as 10% overall.
Managed Care September 2002	Physician prescribing rates climb One reason that spending on medications has increased during the last 15 years is that physicians are turning to pharmaceuticals to help patients battle comorbidities, according to a study in Health Affairs.
Wall Street & Technology June 13, 2006	The Online Generation New research based on consumer survey results reveals that young adults, ages 25 to 34, are between 4% and 10% more likely to research and purchase their financial products online than overall online users.
The Motley Fool July 27, 2007	Shire's Got Focus: Fool by Numbers Revenue and guidance are up at Shire, led by improved sales of their ADHD drugs.
Salon.com September 25, 2000 Lawrence H. Diller, M.D.	Just say yes to Ritalin! Parents are being pressured by schools to medicate their kids -- or else.
Chemistry World October 22, 2012 Andrew Turley	Pfizer to pay $700m for Ritalin re-formulated Pfizer is to buy NextWave, a privately owned pharma company specializing in central nervous system disorders. NextWave is best known for Quillivant XR (methylphenidate hydrochloride) oral suspension, a liquid medication for the treatment of attention deficit hyperactivity disorder.
Managed Care October 2004 Martin Sipkoff	Not So Much of a Reach: Let Sick Pay Less for Drugs The idea is radical and simple: Those who need medication the most should pay the least. There is evidence that this is cost-effective.
The Motley Fool August 1, 2006 Selena Maranjian	Prescription for Prescription Bargains Did you know that your medications might be cheaper around the corner? Another way to offset your net expenses on medications is to make some money on drugs -- by investing in drug-related firms.
Managed Care April 2001	Employers easing prescription limitations? Some older medications once viewed by employers as "lifestyle" drugs when making benefit decisions are slowly gaining recognition as important components of primary care...
ifeminists February 25, 2007 Tony Zizza	ADHD and Coca-Cola Come Up Flat The selling and marketing of alleged mental disorders remains a part of our popular culture. Ever since the FDA finally put black box warnings on ADHD drugs for children, drug companies and the mainstream media have been trying to convince adults that they also suffer from ADHD.
The Motley Fool November 22, 2005 Brian Gorman	Saying No to Drugs Britain's policy of restricting drug access based on cost-benefit analyses should be on the radar screen of pharmaceutical investors.
The Motley Fool March 24, 2006 Brian Gorman	Cephalon Takes a Hit The FDA rules against its ADHD drug, but Cephalon's current lineup still holds promise. Investors may want to look at the current sell-off as a potential buying opportunity.